Innovator IBD 50 ETF Achieves 5-Star Rating from Morningstar 1

The Innovator IBD® 50 ETF tracks the IBD® 50 Index. The CAN SLIM® methodology governing the stock selection of the Index incorporates both fundamental and technical analysis, evaluating current and annual earnings, new products, service or management, stock price performance, leadership, institutional ownership, and the overall market. The Index is reconstituted and rebalanced on a weekly basis and weighted based on the strength of component ratings to maintain the 50 leading growth stocks from a universe of over 7,000 names.

Innovator IBD 50 ETF Achieves 5-Star Rating from Morningstar 2

For more market trends, visit ETFTrends.com.

DWS WEBCAST

Subscribe to our free daily newsletters!
Please enter your email address to subscribe to ETF Trends' newsletters featuring latest news and educational events.